Rainbow Childrens Medicare · NSE: RAINBOW · BSE: 543524

Q4 FY23 results · Jan–Mar 2023

Rainbow Childrens Medicare reported revenue from operations of ₹316.97 crore (up 49.2% from Q4 FY22) and net profit of ₹53.86 crore (up 339.3% from Q4 FY22) for Q4 FY23 (Jan–Mar 2023), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY23Q4 FY22YoYQ3 FY23QoQ
Revenue from operations316.97212.45+49.2%306.40+3.4%
Other income8.906.19+43.8%8.37+6.3%
Total income325.86218.63+49.0%314.77+3.5%
Profit before tax70.1015.76+344.8%78.32−10.5%
Net profit for the period53.8612.26+339.3%58.24−7.5%
Attributable to shareholders of the company53.5912.19+339.5%57.92−7.5%
EPS, basic (₹)5.311.36+290.4%5.74−7.5%
Net margin (%)17.05.819.0
Standalone · ₹ crore
ItemQ4 FY23Q4 FY22YoYQ3 FY23QoQ
Revenue from operations302.73201.15+50.5%290.72+4.1%
Other income8.646.60+31.0%8.24+4.9%
Total income311.37207.75+49.9%298.96+4.2%
Profit before tax71.5517.40+311.2%76.17−6.1%
Net profit for the period55.5814.44+284.9%56.88−2.3%
EPS, basic (₹)5.511.61+242.7%5.63−2.1%
Net margin (%)18.47.219.6
Consolidated
Filed with BSE
19 May 2023, 14:11 IST
Board meeting
14 May 2023
Period
01 Jan 2023 to 31 Mar 2023
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
19 May 2023, 14:11 IST
Board meeting
14 May 2023
Period
01 Jan 2023 to 31 Mar 2023
Review status
Audited
Source
XBRL filing on BSE